Health tech companies Aetion and Cegedim have agreed to combine their data platforms together, to allow clients to gauge how their therapies are performing in the real world.
Israeli company Nucleai is putting artificial intelligence to work to discover why so many cancer patients don’t respond to immunotherapies, with the help of Swiss drugmaker De
The UK’s Royal Society of Chemistry has called for digital techniques to be more widely used as part of a new post-COVID national research strategy that could make scientific discovery happ
People in the UK who are recovering from coronavirus infections will be able to get advice from an online rehabilitation service later this month, says NHS England.
Artificial intelligence (AI) could hold the key to identifying people at risk of pancreatic cancer early, allowing them to start potentially life-saving treatment more quickly.
Another nail has been hammered into the coffin of the pharma model of providing lavish entertainment and other benefits to doctors to encourage prescribing of medicines.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.